Abstract View

Author(s): M Sohil M Shabbir1, Shaikh Imran Kalam2, Aejaz Ahmad3, G.J. Khan4, Md Moiz5, Aman Shaikh6

Email(s): 1mohammadsohil8668@gmail.com

Address:

    1JIIU’s Ali Allana College of Pharmacy Akkalkuwa, Nandurbar
    Maharashtra, India

Published In:   Volume - 3,      Issue - 6,     Year - 2024

DOI: Not Available

 View HTML        View PDF

Please allow Pop-Up for this website to view PDF file.

ABSTRACT:
Due to their convenient medication administration, consistent dosage across tablets, stability under a variety of long-term storage conditions, and ability to be manufactured using high-speed compression, labelling, and packaging equipment, tablets are the most often prescribed dosage form. Technological developments and modifications to the typical compressed tablet are intended to improve both acceptability and bioavailability. Numerous more advanced and effective tablet varieties are being developed to provide a delivery strategy that is comparatively easy to administer. Another kind of membrane-controlled release medication delivery system is the osmotic pump system, which functions as follows. The medication is encapsulated in a water-soluble tablet core that will dissolve or suspend the medication when water is present. Additionally, a multi-layer tablet dosage form is more advantageous than a traditional mono-layer tablet. The gastro-retentive dosage form of FDDS enhances bioavailability and therapeutic efficacy while enabling dose reduction due to consistent therapeutic drug levels. Another system is called MADDS. The term "mucoadhesion" refers to the interaction of a bio adhesive polymer, which may be synthetic or natural in origin, with the mucin layer that lines the whole gastrointestinal tract. An optimal targeted drug delivery system is one that only delivers the medication to its sites of action and not to the organs or tissues that are not its intended target. An optimal controlled drug delivery system is one that delivers the medication at a predefined rate, locally or systematically, for a predetermined amount of time. Therefore, the basic principles of tablets, their technologies, and system types with marketed goods of different dosage forms will be examined in this review paper.

Cite this article:
M Sohil M Shabbir, Shaikh Imran Kalam, Aejaz Ahmad, G.J. Khan, Md Moiz, Aman Shaikh. Fast Dissolving Tablets: A Comprehensive Review.IJRPAS, 2024; 3(6): 100-108.


1.      The theory and practice of Industrial Pharmacy, Leon Lachmann, Herbert A. Lieberman, Joseph L. Kanig. Pg. 293-303, Fourth edition

2.      European Pharmacopoeia, 2004; 1: 628.

3.      L.v. Allen, B. Wang, J.D. Devices,” Rapidly dissolving tablets” US patent No. 2000; 60066, 337.

4.      Kuccherkar, B.S., Badhan, A.C., Mahajan, H.S., Mouth dissolving tablets: A Novel drug delivery system, Pharma. Times, 2003; 35: 3-10.

5.      Amin, A.F., Shah, T.J., Bhadani, M.N., Patel, M.M., Emerging trends in Orally disintegrating tablets, www.pharminfo.net, 2005.

6.      Heinemann, H., Rothe, W., Preparation of porous tablets, US Patent No, 1975; 3, 885, 026.

7.      Knistch, K.W., Production of porous tablets, US Patent No.4, 1979; 134, 843.

8.      Roser, B.J., Blair, J., Rapidly soluble oral dosage form, method of making rapidly disintegrant dosage form, US Patent No.5, 762, 961, 1998.

9.      Bi, Y., Sunada, H., Yonezaway, Y., Jida, K., Preparation and evaluation of a Compressed tablet rapidly disintegrating in oral cavity, Chem. Pharm. Bull, 1996; 44: 2121-2129.

10.  . Lachmann, L., Liebermann, H.A., Kiang, J.L., The Theory and Practice of Industrial Pharmacy, 3rd Ed., Varghese Publishing House, Bombay, 1998; 430- 440.

11.  Kaushik, D, Dureja, H, Saini, T. R., Mouth Dissolving Tablets: A review. Indian Drugs, 2004; 41(4): 187-193.

12.  Yarwood, R.J., Kearny, K., Thomson A.R., Process for preparing solid dosage Form for unpalatable pharmaceuticals, US Patent No. 5, 1998; 738, 875.

13.  Bhaskaran, S., Narmada, G.V., Orally disintegrating tablets, Indian Pharmacist, 2002; 1(2): 9-12

14.  Seager, H., Drug delivery products and zydis fast dissolving dosage form, J. Pharm. Pharmacal, 1998; 50: 375-382.

15.  Greogy, Jaccard and Leyder et al., Fast Dissolving Drug Delivery Systems: A Review, IJPS, July 2002; 331-336

16.   Velmurugan S, Vinushitha S.  Oral disintegrating tablets:  an overview. Int J Chem Pharm Sci 2010; 1:1-12.

17.   Sri KV, Raj GB, Ravishanker D, Kumar CA.  Preparation and evaluation of montelukast oral dispersible tablets by direct compression method. Int Res J Pharm 2012; 7:315-8

18.   Yang D, Kulkarni R, Behme RJ, Kotiyan PN.  Effect of the melt granulation technique on the dissolution characteristics of griseofulvin. Int J Pharm 2007; 329:72-80.

19.   Khan AB, Tripuraneni A.  Fast dissolving tablets–a novel approach in drug delivery. Rguhs J Pharm Sci 2014; 1:7-16.

20.   Chowdary YA, Soumya M, Madhubabu M, Aparna K, Himabindu P.  A review on fast dissolving drug delivery systems-A pioneering drug delivery technology. BEPLS 2012; 1:8-20.

Related Images:



Recent Images



Assessing Philippine Health Care Coverage Gaps: An Assessment of Accessibility of Public Health Programs in Selected Barangay in Imus, Cavite, Philippines
Isoabsorptive UV Spectrophotometry Method development and validation for simultaneous estimation of Eslicarbazepine Acetate and Carbamazepine
To develop and validate the stability indicating method for repaglinide and voglibose using HPLC method
To develop and validate the stability indicating method for Empagliflozin and Linagliptin using HPLC method
A Prospective Observational Study on the Clinical Evaluation of Vertigoin Young Adult Population of Amaravati Capital Region
Quality by Design-Based Analytical Method Development and Validation of Suzetrigine by RP - HPLC
Formulation, Optimization and Evaluation of Rimegepant Pulsatile Tablets for Chronotherapeutic Management of Migraine
Development and Evaluation of Ticagrelor Solid Dispersion Tablets Using PVP K30, PEG 6000 and HPMC E5 for Dissolution Enhancement
To study the effect of various superdisintegrants and binders in the Formulation and Evaluation of Labetalol Rapid Disintegrating Tablet
To Develop and Validate the Stability Indicating Method for Ezetimibe and Rosuvastatin Using HPLC Method

Tags